HIGHLIGHTS
- who: Marion J. F. Levy et al. from the INSERM, , Paris, France have published the research work: High Dose Pharmaceutical Grade Biotin (MD1003) Accelerates Differentiation of Murine and Grafted Human Oligodendrocyte Progenitor Cells In Vivo, in the Journal: (JOURNAL) of 20/04/2005
- what: The authors show that MD1003 increases the number and the potential of endogenous murine oligodendroglia over time.
- how: Initial clinical data showed that daily doses of MD1003 up to 300 mg over 12 months can improve objective measures of MS-related disability . To address the potential benefit of biotin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.